ProQR makes progress with potential treatment for LCA
Despite the challenges of the pandemic, researchers and pharmaceutical companies are still making progress towards delivering new treatments for inherited sight loss.
Search results
Despite the challenges of the pandemic, researchers and pharmaceutical companies are still making progress towards delivering new treatments for inherited sight loss.
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
Biopharmaceutical company ProQR is conducting a Phase 2/3 clinical trial (Illuminate) to measure the safety and effectiveness of RNA therapy, Sepofarsen which aims to treat Leber's Congenital Amourosis (LCA) 10.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP's and for all businesses and other organisations wishing to improve their services for the visually impaired.
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP’s and for all businesses and other organisations wishing to improve their services for the visually impaired.
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP’s and for all businesses and other organisations wishing to improve their services for the visually impaired.
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP’s and for all businesses and other organisations wishing to improve their services for the visually impaired.
The Great North Run is the largest half marathon in the world, taking place annually in Newcastle.
Russ was diagnosed with Choroideremia at the age of 11, after visiting caves in Spain and not being able to see anything.